查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1800203

全球瘧疾診斷市場 - 預測至 2025-2030 年

Global Malaria Diagnostics Market - Forecasts fom 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

瘧疾診斷市場預計將從 2025 年的 710,504,000 美元成長到 2030 年的 908,749,000 美元，複合年成長率為 5.05%。

瘧疾診斷市場蓬勃發展，因為早期準確診斷對於控制這種疾病至關重要。如果不及時治療，瘧疾會導致高發病率和高死亡率。高品質的診斷試劑套件，包括分子診斷和快速診斷檢測 (RDT)，對於有效控制疾病至關重要。技術進步和政府資金的增加推動了瘧疾診斷市場的發展，但部分地區認知度較低，這給市場帶來了挑戰。本概述重點介紹目前的趨勢、促進因素、限制因素和關鍵參與企業，不包括2023年之前的發展。

市場促進因素

瘧疾診斷市場的關鍵驅動力在於診斷技術的進步，尤其是快速診斷（RDT）和分子診斷技術，這些技術能夠快速且準確地檢測瘧疾。這些創新技術能夠及時治療並改善患者預後，尤其是在感染率較高的地區。開發中國家政府增加對瘧疾研究和宣傳宣傳活動的資助也是一個重要的成長要素因素。這些舉措旨在提高診斷的可近性，並教育社區，尤其是在瘧疾流行地區，早期檢測的重要性。全球瘧疾負擔持續凸顯了對高效診斷工具的需求，進一步推動了市場需求。

市場限制

儘管瘧疾診斷市場具有成長潛力，但由於某些地區（尤其是在瘧疾流行的新興國家）公眾認知度較低，該市場仍面臨挑戰。對診斷工具及其益處的了解不足，可能會延遲其應用，並阻礙有效的疾病控制。此外，物流的挑戰，例如偏遠地區醫療基礎設施不足，也可能限制人們獲得先進診斷工具，並限制市場擴張。透過完善教育和分銷網路來克服這些障礙，對於持續成長至關重要。

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 經營狀況

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

5. 瘧疾診斷市場（依技術）

  • 介紹
  • 快速診斷測試（RDT）
  • 顯微鏡
  • 分子診斷
  • 血清學檢測
  • 其他

第6章 瘧疾診斷市場（依最終使用者）

  • 介紹
  • 醫院和診所
  • 診斷實驗室
  • 研究所
  • 非政府組織和政府健康項目

7. 瘧疾診斷市場（依通路）

  • 介紹
  • 直接競標和設施銷售
  • 零售和私營部門

8. 瘧疾診斷市場（按地區）

  • 介紹
  • 北美洲
    • 依技術
    • 按最終用戶
    • 按分銷管道
    • 按國家
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 依技術
    • 按最終用戶
    • 按分銷管道
    • 按國家
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 依技術
    • 按最終用戶
    • 按分銷管道
    • 按國家
      • 英國
      • 德國
      • 法國
      • 西班牙
      • 其他
  • 中東和非洲
    • 依技術
    • 按最終用戶
    • 按分銷管道
    • 按國家
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 其他
  • 亞太地區
    • 依技術
    • 按最終用戶
    • 按分銷管道
    • 按國家
      • 中國
      • 日本
      • 韓國
      • 印度
      • 印尼
      • 泰國
      • 其他

第9章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章：公司簡介

  • Motic（Xiamen）Electric Group Co., Ltd.
  • Sight Diagnostics Ltd.
  • bioMerieux SA
  • Intellectual Ventures Laboratory, LLC
  • Access Bio. Inc.
  • Sysmex Europe GmbH
  • Abbott Laboratories
  • Meridian Bioscience, Inc.
  • QuantuMDx Group Ltd.
  • Hemex Health, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Premier Medical Corporation Pvt. Ltd.

第11章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061611645

The Global Malaria Diagnostics Market is expected to grow from USD 710.504 million in 2025 to USD 908.749 million in 2030, at a CAGR of 5.05%.

The malaria diagnostics market is experiencing growth driven by the critical need for early and accurate diagnosis to manage a disease that causes significant morbidity and mortality if untreated. High-quality diagnostic kits, including molecular diagnostics and rapid diagnostic tests (RDTs), are essential for effective disease management. The market is supported by technological advancements and increased government funding, though low awareness in some regions poses challenges. This summary focuses on current trends, drivers, restraints, and key players, excluding developments prior to 2023.

Market Drivers

The primary driver of the malaria diagnostics market is the advancement in diagnostic technologies, particularly RDTs and molecular diagnostics, which enable rapid and precise detection of malaria. These innovations improve patient outcomes by facilitating timely treatment, especially in high-burden regions. Increased government funding for malaria research and awareness campaigns in developing countries is another key growth factor. These initiatives aim to enhance access to diagnostics and educate communities about the importance of early detection, particularly in endemic areas. The global burden of malaria continues to underscore the need for efficient diagnostic tools, further propelling market demand.

Market Restraints

Despite its growth potential, the malaria diagnostics market faces challenges due to low awareness among populations in certain regions, particularly in developing countries where malaria is prevalent. Limited understanding of diagnostic tools and their benefits can delay adoption and hinder effective disease management. Additionally, logistical challenges, such as inadequate healthcare infrastructure in remote areas, may restrict access to advanced diagnostics, limiting market expansion. Addressing these barriers through education and improved distribution networks is essential for sustained growth.

Market Segmentation

By Diagnostic Type

The market is segmented into molecular diagnostics and RDTs, with RDTs dominating due to their ease of use, affordability, and suitability for point-of-care testing in resource-limited settings. Molecular diagnostics, while more precise, are gaining traction in advanced healthcare systems for their ability to detect low-level infections. Both segments are critical to addressing diverse diagnostic needs across global markets.

By Geography

The malaria diagnostics market is concentrated in high-burden regions, particularly Sub-Saharan Africa and parts of Asia, where malaria prevalence drives demand. Africa remains the largest market due to its significant disease burden and increasing government-led initiatives. The Asia-Pacific region is also growing, supported by rising investments in healthcare infrastructure and awareness programs. Developed regions like North America and Europe contribute through research and development of advanced diagnostic technologies.

Key Industry Players

Major players in the malaria diagnostics market include Motic (Xiamen) Electric Group Co., Ltd., Sight Diagnostics Ltd., bioMerieux SA, Intellectual Ventures Laboratory, LLC, Access Bio, Inc., Sysmex Europe GmbH, Abbott Laboratories, Meridian Bioscience, Inc., QuantuMDx Group Ltd., Hemex Health, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., and Premier Medical Corporation Pvt. Ltd. These companies are driving innovation in diagnostic technologies and expanding access to testing solutions.

The malaria diagnostics market is poised for growth, driven by technological advancements and increased funding for malaria control. Low awareness and logistical challenges remain hurdles, particularly in endemic regions. With a focus on RDTs and molecular diagnostics, and strong growth in Africa and Asia-Pacific, the market is well-positioned to address global malaria challenges, provided stakeholders prioritize education and accessibility.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Malaria Diagnostics Market Segmentation:

By Technology

  • Rapid Diagnostic Tests (RDTs)
  • Microscopy
  • Molecular Diagnostics
  • Serology-based Tests
  • Other Technologies

By End-Users

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • NGOs and Government Health Programs

By Distribution Channel

  • Direct Tenders & Institutional Sales
  • Retail and Private

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. MALARIA DIAGNOSTICS MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. Rapid Diagnostic Tests (RDTs)
  • 5.3. Microscopy
  • 5.4. Molecular Diagnostics
  • 5.5. Serology-based Tests
  • 5.6. Other Technologies

6. MALARIA DIAGNOSTICS MARKET BY END-USERS

  • 6.1. Introduction
  • 6.2. Hospitals and Clinics
  • 6.3. Diagnostic Laboratories
  • 6.4. Research Institutes
  • 6.5. NGOs and Government Health Programs

7. MALARIA DIAGNOSTICS MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Direct Tenders & Institutional Sales
  • 7.3. Retail and Private

8. MALARIA DIAGNOSTICS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Technology
    • 8.2.2. By End-Users
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Technology
    • 8.3.2. By End-Users
    • 8.3.3. By Distribution Channel
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Technology
    • 8.4.2. By End-Users
    • 8.4.3. By Distribution Channel
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Technology
    • 8.5.2. By End-Users
    • 8.5.3. By Distribution Channel
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Technology
    • 8.6.2. By End-Users
    • 8.6.3. By Distribution Channel
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. South Korea
      • 8.6.4.4. India
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Motic (Xiamen) Electric Group Co., Ltd.
  • 10.2. Sight Diagnostics Ltd.
  • 10.3. bioMerieux SA
  • 10.4. Intellectual Ventures Laboratory, LLC
  • 10.5. Access Bio. Inc.
  • 10.6. Sysmex Europe GmbH
  • 10.7. Abbott Laboratories
  • 10.8. Meridian Bioscience, Inc.
  • 10.9. QuantuMDx Group Ltd.
  • 10.10. Hemex Health, Inc.
  • 10.11. F. Hoffmann-La Roche Ltd.
  • 10.12. Bio-Rad Laboratories, Inc.
  • 10.13. Thermo Fisher Scientific Inc.
  • 10.14. Premier Medical Corporation Pvt. Ltd.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations